Results 31 to 40 of about 18,807 (230)

Varicella: to vaccinate or not vaccinate? [PDF]

Archives of Disease in Childhood, 1999
Editor,—Gershon summarised the rationale for universal varicella immunisation and strongly advocated its implementation in developed countries.1 While the reduction of varicella associated morbidity is indeed an important public health goal, it seems warranted to draw attention to epidemiological, political, economic, and cultural characteristics of ...
openaire   +3 more sources

Varicella vaccine

Jornal de Pediatria, 1995
The varicella vaccine developed by Takahashi and cols. in 1974, in Japan, shows outstanding features. Its development, site and route of administration and final results are reviewed in this article.The varicella vaccine is highly effective in normal children (with almost 100% seroconversion rate), and with good protective responses in ...
openaire   +4 more sources

Estimating the basic reproductive number of varicella in South Korea incorporating social contact patterns and seroprevalence

Human Vaccines & Immunotherapeutics, 2021
Varicella, which is caused by the varicella zoster virus (VZV), is a common infectious disease affecting children. Varicella vaccines have been used for decades; however, vaccination policies vary across countries because of differences in VZV ...
Taeyong Lee, Jiyeon Suh, Jae-Ki Choi, Jeehyun Lee, Sun Hee Park   +4 more
doaj   +1 more source

Varicella vaccines and measles, mumps, rubella, and varicella vaccine

Jornal de Pediatria, 2006
To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella.Bibliographic review of the MEDLINE and LILACS databases covering the period 1999 to 2006.The varicella vaccine protects 70 to 90% of ...
Gabriel Wolf Oselka, Helena Keico Sato, Lucia Ferro Bricks   +2 more
openaire   +3 more sources

Impact of subsidies and socioeconomic status on varicella vaccination in Greater Tokyo, Japan

Frontiers in Pediatrics, 2016
Background: Although the control of varicella outbreaks is an important health issue, cost could present a major barrier for vaccination The aim of this study is to investigate the association of vaccine subsidies and caregivers’ socioeconomic status ...
Kei eNagaoka, Takeo eFujiwara
doaj   +1 more source

Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study. [PDF]

PLoS ONE, 2015
To determine if reductions in medically-attended pediatric varicella and herpes zoster occurred in Ontario, Canada, after publicly-funded varicella immunization was implemented in 2004.For fiscal years (FY) 1992-2011, we examined data on varicella and ...
Anne E Wormsbecker, Jun Wang, Laura C Rosella, Jeffrey C Kwong, Chi Yon Seo, Natasha S Crowcroft, Shelley L Deeks   +6 more
doaj   +1 more source

Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B

Advanced Science, EarlyView.
Kaposi's sarcoma‐associated herpesvirus (KSHV) causes severe cancers without effective treatments. This study presents an atomic model of KSHV's critical infection protein, gB, revealing a unique structure shared with related herpesviruses like Epstein‐Barr virus (EBV). The structural similarity highlights vulnerable targets for antibodies, guiding the
Xin‐Yan Fang, Cong Sun, Chu Xie, Bing‐Zhen Cheng, Zheng‐Zhou Lu, Ge‐Xin Zhao, Sen‐Fang Sui, Mu‐Sheng Zeng, Zheng Liu   +8 more
wiley   +1 more source

Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production

Iranian Journal of Allergy, Asthma and Immunology, 2018
Preparation of the indigenous varicella zoster vaccine could significantly reduce the disease burden of varicella zoster virus especially in immunosuppressed children.
Fatemeh Esna-Ashari, Farzaneh Sabahi, Mehrdad Ravanshad, Ashraf Mohammadi   +3 more
doaj   +1 more source

Varicella and Varicella Vaccination in South Korea [PDF]

Clinical and Vaccine Immunology, 2014
ABSTRACTWith continuing occurrence of varicella despite increasing vaccine coverage for the past 20 years, a case-based study, a case-control study, and an immunogenicity and safety study were conducted to address the impact of varicella vaccination in South Korea. Varicella patients under the age of 16 years were enrolled for the case-based study. For
Jae Youn Kim, Nam Hee Kim, Sung-Ho Cha, Eun Hwa Choi, Bo Youl Choi, Yun Kyung Kim, Dae Sun Jo, Eun Hee Chung, Shin Ah Kim, Jin Keun Chang, Jae Kyun Hur, Sung Hee Oh, Kwang Nam Kim, Sang Hyuk Ma, Kyung Hyo Kim, Kyong Min Choi, Su Eun Park, Byung Wook Eun, Seon Hee Shin, Soo Young Lee   +19 more
openaire   +3 more sources

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children

Human Vaccines & Immunotherapeutics, 2022
In Russia, a universal varicella vaccination (UVV) program has not been implemented, and varicella vaccination coverage is low. We assessed the efficacy, antibody persistence, and safety of one- and two-dose varicella vaccination schedules in Russian ...
Leyla Namazova-Baranova, Md Ahsan Habib, Michael Povey, Kamilla Efendieva, Olga Fedorova, Marina Fedoseenko, Tatyana Ivleva, Yulia Kovshirina, Julia Levina, Artem Lyamin, Ludmila Ogorodova, Olga Reshetko, Viktor Romanenko, Inna Ryzhenkova, Irina Sidorenko, Yakov Yakovlev, Aleksandr Zhestkov, Vladimir Tatochenko, Michael Scherbakov, Evgeniy L Shpeer, Giacomo Casabona, on behalf of the OKAH-182 Russia Study Group   +21 more
doaj   +1 more source